Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment

Garrison, 1976, GC/MS analysis of organic compounds in domestic wastewaters, 517

Hignite, 1977, Drugs and drugs metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicylic acid in sewage water effluent, Life Sci., 20, 337, 10.1016/0024-3205(77)90329-0

Richardson, 1985, The fate of pharmaceutical chemicals in the aquatic environment, J. Pharm. Pharmacol., 37, 1, 10.1111/j.2042-7158.1985.tb04922.x

Aherne, 1985, The role of imunoassay in the analysis of microcontaminants in water samples, Ecotoxicol. Environ. Saf., 9, 79, 10.1016/0147-6513(85)90037-5

Aherne, 1990, Cytotoxic drugs and the aquatic environment: estimation of bleomycin in river and water samples, J. Pharm. Pharmacol., 42, 741, 10.1111/j.2042-7158.1990.tb06574.x

Kümmerer, 2001, Introduction: pharmaceuticals in the environment, 1

Pfluger, 2001, Effects on pharmaceuticals in the environment—an overview and principle considerations, 11

Zuccato, 2006, Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control, Environ. Sci. Pollut. Res., 13, 15, 10.1065/espr2006.01.004

Glassmeyer, 2009, Disposal practises for unwanted residential medications in the United States, Environ. Int., 35, 566, 10.1016/j.envint.2008.10.007

Fent, 2006, Ecotoxicology of human pharmaceuticals, Aquat. Toxicol., 76, 122, 10.1016/j.aquatox.2005.09.009

Halling-Sørensen, 1998, Occurrence, fate and effects of pharmaceutical substances in the environment—a review, Chemosphere, 36, 357, 10.1016/S0045-6535(97)00354-8

Dorne, 2007, Trends in human risk assessment of pharmaceuticals, Anal. Bioanal. Chem., 387, 1167, 10.1007/s00216-006-0961-9

Glassmeyer, 2008, Environmental presence and persistence of pharmaceuticals: an overview, 3

Gómez, 2007, Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast, Chemosphere, 66, 993, 10.1016/j.chemosphere.2006.07.051

Tauxe-Wuersch, 2005, Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment, Water Res., 39, 1761, 10.1016/j.watres.2005.03.003

Vieno, 2006, Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography-tandem mass spectrometry detection, J. Chromatogr. A, 1134, 101, 10.1016/j.chroma.2006.08.077

Verenitch, 2006, Determination of acidic drugs and caffeine in municipal wastewaters and receiving waters by gas chromatography-ion trap tandem mass spectrometry, J. Chromatogr. A, 1116, 193, 10.1016/j.chroma.2006.03.005

Lee, 2005, Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid-phase extraction and gas chromatography-mass spectrometry, J. Chromatogr. A, 1094, 122, 10.1016/j.chroma.2005.07.070

Koutsouba, 2003, Determination of polar pharmaceuticals in sewage water of Greece by gas chromatography-mass spectrometry, Chemosphere, 51, 69, 10.1016/S0045-6535(02)00819-6

Moldovan, 2006, Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania, Chemosphere, 64, 1808, 10.1016/j.chemosphere.2006.02.003

Bendz, 2005, Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden, J. Hazard. Mater., 122, 195, 10.1016/j.jhazmat.2005.03.012

Stumpf, 1999, Polar drug residue in sewage and natural waters in the state of Rio de Janeiro, Brazil, Sci. Total Environ., 225, 135, 10.1016/S0048-9697(98)00339-8

Kolpin, 2002, Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance, Environ. Sci. Technol., 36, 1202, 10.1021/es011055j

Calamari, 2003, Strategic survey of therapeutic drugs in the Rivers Po and Lambro in Northern Italy, Environ. Sci. Technol., 37, 1241, 10.1021/es020158e

Weigel, 2002, Drugs and personal care products as ubiquitious pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea, Sci. Total Environ., 295, 131, 10.1016/S0048-9697(02)00064-5

Sacher, 2001, Pharmaceuticals in groundwaters. Analytical methods and results of a monitoring program in Baden-Württemberg, Germany, J. Chromatogr. A, 938, 199, 10.1016/S0021-9673(01)01266-3

Batt, 2006, Occurrence of sulfonamide antimicrobials in private water wells in Washington County, Idaho, USA, Chemosphere, 64, 1963, 10.1016/j.chemosphere.2006.01.029

Barnes, 2008, A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States—I) Groundwater, Sci. Total Environ., 402, 192, 10.1016/j.scitotenv.2008.04.028

Potera, 2000, Drugged drinking water, Environ. Health Perspect., 108, A446, 10.2307/3435035

Loos, 2007, Polar herbicides, pharmaceutical products, perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and nonylphenol and its carboxylates and ethoxylates in surface and tap waters around Lake Maggiore in Northern Italy, Anal. Bioanal. Chem., 387, 1469, 10.1007/s00216-006-1036-7

Focazio, 2008, A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States—II) Untreated drinking water sources, Sci. Total Environ., 402, 201, 10.1016/j.scitotenv.2008.02.021

Benotti, 2009, Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water, Environ. Sci. Technol., 43, 597, 10.1021/es801845a

Péry, 2008, Fluoxetine effects assessment on the life cycle of aquatic invertebrates, Chemosphere, 73, 300, 10.1016/j.chemosphere.2008.06.029

Kidd, 2007, Collapse of a fish population after exposure to a synthetic estrogen, Proc. Natl. Acad. Sci. U.S.A., 104, 8897, 10.1073/pnas.0609568104

Daughton, 1999, Pharmaceuticals and personal care products in the environment: agents of subtle changes?, Environ. Health Perspect., 107, 907, 10.1289/ehp.99107s6907

Timbrell, 2002

Braund, 2009, Disposal practises for unused medications in New Zeland, Environ. Int., 35, 952, 10.1016/j.envint.2009.04.003

Persson, 2009, Handling of unused prescription drugs—knowledge, behaviour and attitude among Swedish people, Environ. Int., 35, 771, 10.1016/j.envint.2008.10.002

Heberer, 2002, Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data, Toxicol. Lett., 131, 5, 10.1016/S0378-4274(02)00041-3

Bound, 2005, Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom, Environ. Health Perspect., 113, 1705, 10.1289/ehp.8315

Xia, 2005, Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids, J. Environ. Qual., 34, 91, 10.2134/jeq2005.0091

Topp, 2008, Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field, Sci. Total Environ., 396, 52, 10.1016/j.scitotenv.2008.02.011

Kemper, 2008, Veterinary antibiotics in the aquatic and terrestrial environment, Ecol. Indic., 8, 1, 10.1016/j.ecolind.2007.06.002

Kay, 2005, Transport of veterinary antibiotics in overland flow following the application of slurry to arable land, Chemosphere, 59, 951, 10.1016/j.chemosphere.2004.11.055

Le, 2004, Residues of selected antibiotics in water and mud from shrimp ponds in mangrove areas in Viet Nam, Marine Pollut. Bull., 49, 922, 10.1016/j.marpolbul.2004.06.016

Lalumera, 2004, Preliminary investigation on the environmental occurrence and effects of antibiotics used in aquaculture in Italy, Chemosphere, 54, 661, 10.1016/j.chemosphere.2003.08.001

Lin, 2009, Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical production facilities, Sci. Total Environ., 407, 3793, 10.1016/j.scitotenv.2009.03.009

Li, 2008, Determination of penicillin G and its degradation products in a penicillin production wastewater treatment plant and the receiving river, Water Res., 42, 307, 10.1016/j.watres.2007.07.016

Larsson, 2007, Effluent from drug manufactures contains extremely high levels of pharmaceuticals, J. Hazard. Mater., 148, 751, 10.1016/j.jhazmat.2007.07.008

Boreen, 2003, Photodegradation of pharmaceuticals in the aquatic environment: a review, Aquat. Sci., 65, 320, 10.1007/s00027-003-0672-7

Bartels, 2007, Solar radiation influence on the decomposition process of diclofenac in surface waters, Sci. Total Environ., 374, 143, 10.1016/j.scitotenv.2006.11.039

Crane, 2006, Chronic aquatic environmental risks from exposure to human pharmaceuticals, Sci. Total Environ., 367, 23, 10.1016/j.scitotenv.2006.04.010

Roberts, 2006, The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment, Sci. Total Environ., 356, 143, 10.1016/j.scitotenv.2005.04.031

Ternes, 1998, Occurrence of drugs in German sewage treatment plants and rivers, Water Res., 32, 3245, 10.1016/S0043-1354(98)00099-2

Lindqvist, 2005, Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters, Water Res., 39, 2219, 10.1016/j.watres.2005.04.003

Sedlak, 2001, Factors affecting the concentrations of pharmaceuticals released to the aquatic environment, Water Resour. Update, 120, 56

Cirja, 2008, Factors affecting the removal of organic micropollutants from wastewater in conventional treatment plants (CTP) and membrane bioreactors (MBR), Rev. Environ. Sci. Biotechnol., 7, 61, 10.1007/s11157-007-9121-8

Kümmerer, 2001, Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources—a review, Chemosphere, 45, 957, 10.1016/S0045-6535(01)00144-8

Lin, 2008, Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan, Chemosphere, 74, 131, 10.1016/j.chemosphere.2008.08.027

Zwiener, 2001, Pharmaceutical residues in the aquatic environment and their significance for drinking water production, 81

Stackelberg, 2004, Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant, Sci. Total Environ., 329, 99, 10.1016/j.scitotenv.2004.03.015

Vane, 1998, Mechanism of action of antiinflammatory drugs, Int. J. Tissue React., 20, 3

Zou, 1999, Fish macrophages express a cyclo-oxygenase-2 homologue after activation, Biochem. J., 340, 153, 10.1042/bj3400153

Lundholm, 1997, DDE-induced eggshell thinning in birds: effects of p,p’-DDE on the calcium and prostaglandin metabolism of the eggshell gland, Comp. Biol. Physiol., 118C, 113

Cleuvers, 2003, Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects, Toxicol. Lett., 142, 185, 10.1016/S0378-4274(03)00068-7

Schwaiger, 2004, Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout, Aquat. Toxicol., 68, 141, 10.1016/j.aquatox.2004.03.014

Triebskorn, 2004, Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss), Aquat. Toxicol., 68, 151, 10.1016/j.aquatox.2004.03.015

Hoeger, 2005, Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario), Aquat. Toxicol., 75, 53, 10.1016/j.aquatox.2005.07.006

Schmitt-Jansen, 2007, Phytotoxicity assessment of diclofenac and its phototransformation products, Anal. Bioanal. Chem., 387, 1389, 10.1007/s00216-006-0825-3

DeLorenzo, 2008, Individual and mixture effects of selected pharmaceuticals and personal care products on the marine phytoplankton species Dunaliella tertiolecta, Arch. Environ. Contam. Toxicol., 54, 203, 10.1007/s00244-007-9032-2

Hernando, 2006, Trace-level determination of pharmaceuticals residues by LC–MS/MS in natural and treated waters. A pilot-survey study, Anal. Bioanal. Chem., 385, 985, 10.1007/s00216-006-0394-5

Weigel, 2004, Simultaneous solid-phase extraction of acidic, neutral and basic pharmaceuticals from aqueous samples at ambient (neutral) pH and their determination by gas chromatography-mass spectrometry, J. Chromatogr. A, 1023, 183, 10.1016/j.chroma.2003.10.036

Gómez, 2006, Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters, J. Chromatogr. A, 1114, 224, 10.1016/j.chroma.2006.02.038

Flippin, 2007, Changes in the timing of reproduction following chronic exposure to ibuprofen in Japanese medaka, Oryzias latipes, Aquat. Toxicol., 81, 73, 10.1016/j.aquatox.2006.11.002

Heckamann, 2007, Chronic toxicity of ibuprofen to Daphnia magna: effects on life history traits and population dynamics, Toxicol. Lett., 172, 137, 10.1016/j.toxlet.2007.06.001

De Lange, 2006, Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals, Aquat. Toxicol., 78, 209, 10.1016/j.aquatox.2006.03.002

Pomati, 2004, Effects of erythromycin, tetraycline and ibuprofen on the growth of Synechocystis sp. and Lemna minor, Aquat. Toxicol., 67, 387, 10.1016/j.aquatox.2004.02.001

Kim, 2009, Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes), J. Toxicol. Sci., 34, 227, 10.2131/jts.34.227

Pounds, 2008, Acute and chronic effects of ibuprofen in the mollusc Planorbis carinatus (Gastropoda: Planorbidae), Ecotoxicol. Environ. Saf., 70, 47, 10.1016/j.ecoenv.2007.07.003

Isidori, 2005, Ecotoxicity of naproxen and its phototransformation products, Sci. Total Environ., 348, 93, 10.1016/j.scitotenv.2004.12.068

Thomas, 2004, Determination of nonsteroidal anti-inflammatory drugs, caffeine, and triclosan in wastewater by gas chromatography-mass spectrometry, J. Environ. Sci. Health. Part A Toxic/Hazard. Subst. Environ. Eng., A39, 1969, 10.1081/ESE-120039368

Kim, 2007, Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea, Environ. Int., 33, 275, 10.1016/j.envint.2006.11.017

Henschel, 1997, Environmental hazard assessment of pharmaceuticals, Regul. Toxicol. Pharm., 25, 220, 10.1006/rtph.1997.1102

Grujić, 2009, Determination of multiple pharmaceutical classes in surface and ground waters by liquid chromatography-ion trap-tandem mass spectrometry, J. Chromatogr. A, 1216, 4989, 10.1016/j.chroma.2009.04.059

Carlsson, 2006, Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients, Sci. Total Environ., 364, 67, 10.1016/j.scitotenv.2005.06.035

Nakada, 2006, Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment, Water Res., 40, 3297, 10.1016/j.watres.2006.06.039

Lin, 2009, Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan, J. Hazard. Mater.

Zhao, 2009, Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry, Sci. Total Environ., 407, 962, 10.1016/j.scitotenv.2008.09.048

Pailler, 2009, Solid phase extraction coupled to liquid chromatography-tandem mass spectrometry analysis of sulfonamides, tetracyclines, analgesics and hormones in surface water and wastewater in Luxembourg, Sci. Total Environ., 407, 4736, 10.1016/j.scitotenv.2009.04.042

Kim, 2007, Water Res., 41, 1013, 10.1016/j.watres.2006.06.034

Bueno, 2009, Evaluation of various liquid chromatography-quadrupole-linear ion trap-mass spectrometry operation modes applied to the analysis of organic pollutants in wastewaters, J. Chromatogr. A, 1216, 5995, 10.1016/j.chroma.2009.06.047

Kim, 2009, Occurrence of pharmaceutical and personal care products (PPCPs) in surface water from Mankyung River, South Korea, J. Health Sci., 55, 249, 10.1248/jhs.55.249

Choi, 2008, Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea, Sci. Total Environ., 405, 120, 10.1016/j.scitotenv.2008.06.038

Hilton, 2003, Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry, J. Chromatogr. A, 1015, 129, 10.1016/S0021-9673(03)01213-5

Cleuvers, 2004, Mixture toxicity of anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid, Ecotoxicol. Environ. Saf., 59, 309, 10.1016/S0147-6513(03)00141-6

Ferrari, 2003, Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac, Ecotoxicol. Environ. Saf., 55, 359, 10.1016/S0147-6513(02)00082-9

Triebskorn, 2007, Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio), Anal. Bioanal. Chem., 387, 1405, 10.1007/s00216-006-1033-x

Quinn, 2008, An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuate, Sci. Total Environ., 389, 306, 10.1016/j.scitotenv.2007.08.038

Rang, 1999

Aguilar-Salinas, 1998, Metabolic modes of action of the statins in the hyperlipoproteinemias, Atherosclerosis, 141, 203, 10.1016/S0021-9150(98)00198-1

Key, 2008, Effects of the statin antihyperlipidemic agent simvastatin on grass shrimp, Palaemonetes pugio, Environ. Toxicol., 23, 153, 10.1002/tox.20318

Dahl, 2006, Application of growth-related sublethal endpoints in ecotoxicological assessments using a harpacticoid copepod, Aquat. Toxicol., 77, 433, 10.1016/j.aquatox.2006.01.014

Brain, 2004, Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum, Aquat. Toxicol., 70, 23, 10.1016/j.aquatox.2004.06.011

Debernard, 1994, The HMG-CoA reductase inhibitor fluvastatin inhibits insect juvenile hormone biosynthesis, Gen. Comp. Endocrinol., 95, 92, 10.1006/gcen.1994.1105

Miao, 2003, Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography-electrospray ionization tandem mass spectrometry, J. Chromatogr. A, 998, 133, 10.1016/S0021-9673(03)00645-9

Miao, 2003, Determination of pharmaceuticals in aqueous samples using positive and negative voltage switching microbore liquid chromatography/electrospray ionization tandem mass spectrometry, J. Mass Spectrom., 38, 27, 10.1002/jms.394

Staels, 1998, Mechanism of action of fibrates on lipid and lipoprotein metabolism, Circulation, 98, 2088, 10.1161/01.CIR.98.19.2088

Sanderson, 2004, Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular, and sex hormones, Toxicology, 203, 27, 10.1016/j.tox.2004.05.015

Ibabe, 2005, Modulation of peroxisome proliferator-activated receptors (PPARs) by PPARα- and PPARγ-specific ligands and by 17β-estradiol in isolated zebrafish hepatocytes, Toxicol. In Vitro, 19, 725, 10.1016/j.tiv.2005.03.019

Raldúa, 2008, Clofibrate and gemfibrozil induce an embryonic malabsorption syndrome in zebrafish, Toxicol. Appl. Pharmacol., 228, 301, 10.1016/j.taap.2007.11.016

Kliewer, 1997, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferation-activated receptors α and γ, Proc. Natl. Acad. Sci. U.S.A., 94, 4318, 10.1073/pnas.94.9.4318

Zurita, 2007, Toxicological effects of the lipid regulator gemfibrozil in four aquatic systems, Aquat. Toxicol., 81, 106, 10.1016/j.aquatox.2006.11.007

Isidori, 2007, Toxic and genotoxic impact of fibrates and their photoproducts on non-target organism, Environ. Int., 33, 635, 10.1016/j.envint.2007.01.006

Mimeault, 2005, The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus, Aquat. Toxicol., 73, 44, 10.1016/j.aquatox.2005.01.009

Emblidge, 2006, Preliminary risk assessment of the lipid-regulating pharmaceutical clofibric acid, for three estuarine species, Environ. Res., 100, 216, 10.1016/j.envres.2005.03.014

Flaherty, 2005, Effects of pharmaceuticals on Daphnia survival, growth, and reproduction, Chemosphere, 61, 200, 10.1016/j.chemosphere.2005.02.016

Runnalls, 2007, Preliminary studies into the effects of the human pharmaceutical Clofibric acid on sperm parameters in adult Fathead minnow, Aquat. Toxicol., 84, 111, 10.1016/j.aquatox.2007.06.005

Castiglioni, 2005, A multiresidue analytical method using solid-phase extraction and high-pressure chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters, J. Chromatogr. A, 1092, 206, 10.1016/j.chroma.2005.07.012

Reddersen, 2003, Multi-compound methods for the detection of pharmaceutical residues in various waters applying solid phase extraction (SPE) and gas chromatography with mass spectrometric (GC–MS) detection, J. Sep. Sci., 26, 1443, 10.1002/jssc.200301533

Jones, 2002, Aquatic environmental assessment of the top 25 English prescription pharmaceuticals, Water Res., 36, 5013, 10.1016/S0043-1354(02)00227-0

Halling-Sørensen, 2000, Algal toxicity of antibacterial agents used in intensive farming, Chemosphere, 40, 731, 10.1016/S0045-6535(99)00445-2

Holten Lützhøft, 1999, Algal toxicity of antibacterial agents applied in Danish farming, Arch. Environ. Contam. Toxicol., 36, 1, 10.1007/s002449900435

Lanzky, 1997, The toxic effect of the antibiotic metronidazole on aquatic organisms, Chemosphere, 35, 2553, 10.1016/S0045-6535(97)00324-X

Isidori, 2005, Toxic and genotoxic evaluation of six antibiotics on non-target organisms, Sci. Total Environ., 346, 87, 10.1016/j.scitotenv.2004.11.017

Kümpel, 2001, What do we know about antibiotics in the environment?, 67

Andreozzi, 2004, Antibiotics in the environment: occurrence in Italian STPs, fate, and preliminary assessment on algal toxicity of amoxicillin, Environ. Sci. Technol., 38, 6832, 10.1021/es049509a

Nie, 2009, Effects of norfloxacin and butylated hydroxyanisole on the freshwater microalga Scenedesmus obliquus, Ecotoxicology, 18, 677, 10.1007/s10646-009-0334-1

Boxall, 2003, Are veterinary medicines causing environmental risks?, Environ. Sci. Technol., 37, 286A, 10.1021/es032519b

Migliore, 1998, Laboratory models to evaluate phytotoxicity of sulphadimethoxine on terrestrial plants, Chemosphere, 37, 2957, 10.1016/S0045-6535(98)00336-1

Costanzo, 2005, Ecosystem response to antibiotics entering the aquatic environment, Mar. Pollut. Bull., 51, 218, 10.1016/j.marpolbul.2004.10.038

Eguchi, 2004, Evaluation of antimicrobial agents for veterinary use in the ecotoxicity test using microalgae, Chemosphere, 57, 1733, 10.1016/j.chemosphere.2004.07.017

Yamashita, 2006, Effects of antibacterial agents, levofloxacin and clarithromycin, on aquatic organisms, Water Sci. Technol., 53, 65, 10.2166/wst.2006.338

Pro, 2003, Effect assessment of antimicrobial pharmaceuticals on the aquatic plant Lemna minor, Bull. Environ. Contam. Toxicol., 70, 290, 10.1007/s00128-002-0208-1

Wollenberger, 2000, Acute and chronic toxicity of veterinary antibiotics to Daphnia magna, Chemosphere, 40, 723, 10.1016/S0045-6535(99)00443-9

De Liguoro, 2009, The toxicity of sulfamethazine to Daphnia magna and its additivity to other veterinary sulfonamides and trimethoprim, Chemosphere, 75, 1519, 10.1016/j.chemosphere.2009.02.002

Park, 2008, Hazard assessment of commonly used agricultural antibiotics on aquatic ecosystems, Ecotoxicology, 17, 526, 10.1007/s10646-008-0209-x

Jiao, 2008, Aqueous photolysis of tetracycline and toxicity of photolytic products to luminescent bacteria, Chemosphere, 73, 377, 10.1016/j.chemosphere.2008.05.042

Brown, 2006, Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico, Sci. Total Environ., 366, 772, 10.1016/j.scitotenv.2005.10.007

Seifrtová, 2008, Determination of fluoroquinolone antibiotics in hospital and municipal wastewaters in Coimbra by liquid chromatography with a monolithic column and fluorescence detection, Anal. Bioanal. Chem., 391, 799, 10.1007/s00216-008-2020-1

Karthikeyan, 2006, Occurrence of antibiotics in wastewater treatment facilities in Wiscosin, USA, Sci. Total Environ., 361, 196, 10.1016/j.scitotenv.2005.06.030

Lindberg, 2005, Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden, Environ. Sci. Technol., 39, 3421, 10.1021/es048143z

Pena, 2007, Determination of fluorquinolone antibiotics in surface waters from Mondego River by high performance liquid chromatography using a monolithic column, J. Sep. Sci., 30, 2924, 10.1002/jssc.200700363

Perret, 2006, Sulphonamide residues in Italian surface and drinking waters: a small scale reconnaissance, Chromatographia, 63, 225, 10.1365/s10337-006-0737-6

Gulkowska, 2007, The occurrence of selected antibiotics in Hong Kong coastal waters, Mar. Pollut. Bull., 54, 1287, 10.1016/j.marpolbul.2007.04.008

Xu, 2007, Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry, Environ. Pollut., 145, 672, 10.1016/j.envpol.2006.05.038

Larsson, 1999, Ethinylestradiol—an undesired fish contraceptive?, Aquat. Toxicol., 45, 91, 10.1016/S0166-445X(98)00112-X

Jobling, 1998, Widespread sexual disruption in wild fish, Environ. Sci. Technol., 32, 2498, 10.1021/es9710870

Parrott, 2005, Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1ng/L reduces egg fertilization success and desmasculinizes males, Environ. Toxicol., 20, 131, 10.1002/tox.20087

Pawlowski, 2004, Effects of 17α-ethinylestradiol in a fathead minnow (Pimephales promelas) gonadal recrudescence assay, Ecotoxicol. Environ. Saf., 57, 330, 10.1016/j.ecoenv.2003.07.019

Örn, 2003, Gonad development and vitellogenin production in zebrafish (Danio rerio) exposed to ethinylestradiol and methyltestosterone, Aquat. Toxicol., 65, 397, 10.1016/S0166-445X(03)00177-2

Nash, 2004, Long-term exposure to environmental concentrations of the pharmaceutical ethynylestradiol causes reproductive failure in fish, Environ. Health Perspect., 112, 1725, 10.1289/ehp.7209

Xu, 2008, Exposure to 17α-ethynylestradiol impairs reproductive functions of both male and female zebrafish (Danio rerio), Aquat. Toxicol., 88, 1, 10.1016/j.aquatox.2008.01.020

Katsu, 2007, Functional associations between two estrogen receptors, environmental estrogens, and sexual disruption in the roach (Rutilus rutilus), Environ. Sci. Technol., 41, 3368, 10.1021/es062797l

Hirai, 2006, Feminization of Japanese medaka (Oryzias latipes) exposed to 17β-estradiol: Formation of testis-ova and sex-transformation during early-ontogeny, Aquat. Toxicol., 77, 78, 10.1016/j.aquatox.2005.11.001

Kang, 2002, Effect of 17β-estradiol on the reproduction of Japanese medaka (Oryzias latipes), Chemosphere, 47, 71, 10.1016/S0045-6535(01)00205-3

Orlando, 2007, Sexual dimorphic responses in wildlife exposed to endocrine disrupting chemicals, Environ. Res., 104, 163, 10.1016/j.envres.2006.06.002

Gyllenhammar, 2009, Reproductive toxicity in Xenopus tropicalis afeter developmental exposure to environmental concentrations of ethynylestradiol, Aquat. Toxicol., 91, 171, 10.1016/j.aquatox.2008.06.019

Vandenbergh, 2003, Effects of 17α-ethinylestradiol on sexual development of the amphipod Hyalella azteca, Ecotoxicol. Environ. Saf., 54, 216, 10.1016/S0147-6513(02)00030-1

Jukosky, 2008, Elevated concentrations of ethinylestradiol, 17β-estradiol, and medroxyprogesterone have little effect on reproduction and survival of Ceriodaphnia dubia, Bull. Environ. Contam. Toxicol., 81, 230, 10.1007/s00128-008-9462-1

Isobe, 2003, Determination of estrogens and their conjugates in water using solid-phase extraction followed by liquid chromatography-tandem mass spectrometry, J. Chromatogr. A, 984, 195, 10.1016/S0021-9673(02)01851-4

Zuehlke, 2005, Determination of estrogenic steroids in surface water and wastewater by liquid chromatography-electrospray tandem mass spectrometry, J. Sep. Sci., 28, 52, 10.1002/jssc.200301727

Yang, 2006, Solid-phase microextraction with on-fiber silylation for simultaneous determinations of endocrine disrupting chemicals and steroid hormones by gas chromatography-mass spectrometry, J. Chromatogr. A, 1104, 23, 10.1016/j.chroma.2005.11.108

Laganà, 2004, Analytical methodologies for determining the occurrence of endocrine disrupting chemicals in sewage treatment plants and natural waters, Anal. Chim. Acta, 501, 79, 10.1016/j.aca.2003.09.020

Vulliet, 2008, Multi-residue analysis of steroids at sub-ng/L levels in surface and ground-waters using liquid chromatography coupled to tandem mass spectrometry, J. Chromatogr. A, 1210, 84, 10.1016/j.chroma.2008.09.034

Thacker, 2005, Pharmaceutical data elude researchers, Environ. Sci. Technol., 39, 193A

Lürling, 2006, Life-history consequences for Daphnia pulex exposed to pharmaceutical carbamazepine, Environ. Toxicol., 21, 172, 10.1002/tox.20171

Oetken, 2005, Effects of pharmaceuticals on aquatic invertebrates. Part I. The antiepileptic drug carbamazepine, Arch. Environ. Contam. Toxicol., 49, 353, 10.1007/s00244-004-0211-0

Sacher, 2008, Pharmaceutical residues in the river Rhine—results of a one-decade monitoring programme, J. Environ. Monit., 10, 664, 10.1039/b800701b

Leclercq, 2009, Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants, Arch. Environ. Contam. Toxicol., 56, 408, 10.1007/s00244-008-9202-x

Nickerson, 2001, A putative β2-adrenoceptor from the rainbow trout (Oncorhyncus mykiss). Molecular characteristion and pharmacology, Eur. J. Biochem., 268, 6465, 10.1046/j.0014-2956.2001.02600.x

Haider, 2000, β-Adrenoceptor antagonists reinitiate meiotic maturation in Clarias batrachus oocytes, Comp. Biochem. Physiol. A, 126, 517, 10.1016/S1095-6433(00)00222-1

Huggett, 2002, Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-Blockers) on aquatic organisms, Arch. Environ. Contam. Toxicol., 43, 229, 10.1007/s00244-002-1182-7

Larsson, 2006, Is heart rate in fish a sensitive indicator to evaluate acute effects of β-blockers in surface water?, Environ. Toxicol. Pharmacol., 22, 338, 10.1016/j.etap.2006.05.002

Winter, 2008, Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas), Aquat. Toxicol., 86, 361, 10.1016/j.aquatox.2007.11.017

Cleuvers, 2005, Initial risk assessment for three β-blockers found in the aquatic environment, Chemosphere, 59, 199, 10.1016/j.chemosphere.2004.11.090

Dzialowski, 2006, Physiological and reproductive effects of beta adrenergic receptor antagonists in Daphnia magna, Arch. Environ. Contam. Toxicol., 50, 503, 10.1007/s00244-005-0121-9

Brooks, 2003, Aquatic ecotoxicology of fluoxetine, Toxicol. Lett., 142, 169, 10.1016/S0378-4274(03)00066-3

Fong, 1998, Zebra mussel spawning is induced in low concentrations of putative serotonin reuptake inhibitors, Biol. Bull., 194, 143, 10.2307/1543044

Nentwing, 2007, Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine, Arch. Environ. Contam. Toxicol., 52, 163, 10.1007/s00244-005-7190-7

Foran, 2004, Reproductive assessment of Japanese medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure, Arch. Environ. Contam. Toxicol., 46, 511, 10.1007/s00244-003-3042-5

Henry, 2008, Acute and chronic toxicity of fluoxetine (selective serotonin reuptake inhibitor) in western mosquitofish, Arch. Environ. Contam. Toxicol., 54, 325, 10.1007/s00244-007-9018-0

Minagh, 2009, Aquatic ecotoxicity of the selective serotonin reuptake inhibitor sertraline hydrochloride in a battery of freshwater test species, Ecotoxicol. Environ. Saf., 72, 434, 10.1016/j.ecoenv.2008.05.002

Johnson, 2007, Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae, Ecotoxicol. Environ. Saf., 67, 128, 10.1016/j.ecoenv.2006.03.016

Brooks, 2003, Waterborne and sediment toxicity of fluoxetine to select organisms, Chemosphere, 52, 135, 10.1016/S0045-6535(03)00103-6

Cunningham, 2004, Environmental risk assessment of paroxetine, Environ. Sci. Technol., 38, 3351, 10.1021/es035119x

Vasskog, 2006, Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway, J. Chromatogr. A, 1115, 187, 10.1016/j.chroma.2006.02.091

Vasskog, 2008, Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway, J. Chromatogr. A, 1185, 194, 10.1016/j.chroma.2008.01.063

Lajeunesse, 2008, Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass, Anal. Chem., 80, 5325, 10.1021/ac800162q

Johnson, 2008, Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study, J. Hydrol., 348, 167, 10.1016/j.jhydrol.2007.09.054

Grung, 2008, Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline, Ecotoxicol. Environ. Saf., 71, 328, 10.1016/j.ecoenv.2007.10.015

DellaGreca, 2007, Phototransformation products of tamoxifen by sunlight in water. Toxicity of the drug and its derivatives on aquatic organisms, Chemosphere, 67, 1933, 10.1016/j.chemosphere.2006.12.001

Steger-Hartmann, 1997, Biological degradation of cyclophosphamide and its occurrence in sewage water, Ecotoxicol. Environ. Saf., 36, 174, 10.1006/eesa.1996.1506

Buerge, 2006, Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters, Environ. Sci. Technol., 40, 7242, 10.1021/es0609405

Zhou, 2009, Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water, J. Hazard. Mater., 166, 655, 10.1016/j.jhazmat.2008.11.070

Pérez, 2007, Fate and occurrence of X-ray contrast media in the environment, Anal. Bioanal. Chem., 387, 1235, 10.1007/s00216-006-0953-9

Steger-Hartmann, 2002, Investigations into the environmental fate and effects of iopromide (ultravist), a widely used iodinated X-ray contrast medium, Water Res., 36, 266, 10.1016/S0043-1354(01)00241-X

Steger-Hartmann, 1999, Environmental risk assessment for the widely used iodinated X-ray contrast agent iopromide (Ultravist), Ecotoxicol. Environ. Saf., 42, 274, 10.1006/eesa.1998.1759

Carballa, 2004, Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant, Water Res., 38, 2918, 10.1016/j.watres.2004.03.029

Ternes, 2000, Occurrence and behavior of X-ray contrast media in sewage facilities and the aquatic environment, Environ. Sci. Technol., 34, 2741, 10.1021/es991118m

Trenholm, 2006, Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry, Chemosphere, 65, 1990, 10.1016/j.chemosphere.2006.07.004

Busetti, 2008, Rapid analysis of iodinated X-ray contrast media in secondary and tertiary treated wastewater by direct injection liquid-chromatography-tandem mass spectrometry, J. Chromatogr. A, 1213, 200, 10.1016/j.chroma.2008.10.021

Seitz, 2006, Monitoring of iodinated X-ray contrast media in surface water, Chemosphere, 64, 1318, 10.1016/j.chemosphere.2005.12.030

Putschew, 2000, Occurrence of triiodinated X-ray contrast agents in the aquatic environment, Sci. Total Environ., 255, 129, 10.1016/S0048-9697(00)00461-7

Hirsch, 2000, A sensitive method for the determination of iodine containing diagnostic agents in aqueous matrices using LC-electrospray-tandem-MS detection, Fresenius J. Anal. Chem., 366, 835, 10.1007/s002160051581

Farré, 2008, Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment, Trends Anal. Chem., 27, 991, 10.1016/j.trac.2008.09.010

García-Galán, 2008, Identification and determination of metabolites and degradation products of sulfonamide antibiotics, Trends Anal. Chem., 27, 1008, 10.1016/j.trac.2008.10.001

Quinn, 2009, Evaluation of the acute, chronic and teratogenic effects of a mixture of eleven pharmaceuticals on the cnidarian, Hydra attenuata, Sci. Total Environ., 407, 1072, 10.1016/j.scitotenv.2008.10.022

Borgmann, 2007, Effect of a mixture of seven pharmaceuticals on Hyalella azteca over multiple generations, Chemosphere, 66, 1278, 10.1016/j.chemosphere.2006.07.025

Parrott, 2009, Life-cycle exposure of fathead minnows to a mixture of six common pharmaceuticals and triclosan, J. Toxicol. Environ. Health A, 72, 633, 10.1080/15287390902769428

Comission Directive 92/18/EEC, Modifying the Annex to Council Directive 81/852/EEC on the Approximation of the Laws of Member States Relating to Analytical, Pharmacotoxicological and Clinical Standards and Protocols in Respect of the Testing of Veterinary Medicinal Products, 1992.

EMEA, Note for Guidance: Environmental Risk Assessment for Veterinary Medicinal Products Other Than GMO-Containing and Immunological Products, The European Agency for the Evaluation of Medicinal Products: Veterinary Medicines Evaluation Unit, EMEA/CVMP/055/96-FINAL, 1998.

EudraLex – Volume 1 – Pharmaceutical Legislation Medicinal Products for Human Use, On line at: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol1_en.htm (accessed in 16 February 2009).

EMEA, Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use, The European Agency for the Evaluation of Medicinal Products: Committee for Medicinal Products for Human Use, EMEA/CHMP/SWP/4447/00, 2006.

FDA, Guidance for Industry: Environmental Assessment of Human Drug and Biologics Applications, Food and Drug Administration (Center for Drug Evaluation and Research), CMC 6, Revision 1, 1998.

EMEA, Guideline on Environmental Impact Assessment (EIAs) for Veterinary Medicinal Products—Phase I, The European Agency for the Evaluation of Medicinal Products: Committee for Medicinal Products for Veterinary Use, CVMP/VICH/592/98-FINAL, 2000.

EMEA, Guideline on Environmental Impact Assessment for Veterinary Medicinal Products—Phase II, The European Agency for the Evaluation of Medicinal Products: Committee for Medicinal Products for Veterinary Use, CVMP/VICH/790/03-FINAL, 2005.